Assessment of beta-2 microglobulin and CD49d in patients with chronic lymphocytic leukemia pre- and posttherapy
BACKGROUND: Chronic lymphocytic leukemia (CLL) is the most common type of leukemia among adults in Western countries; however, it is relatively rare in Asia. It is characterized by abnormal proliferation of lymphocytes in the blood, bone marrow, and lymphatic tissue. The measurement of serum beta-2...
Main Authors: | Abdulameer Nasser Al-Rekabi, Alaa Fadhil Alwan, Naseer Khaleel Alobaidi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Iraqi Journal of Hematology |
Subjects: | |
Online Access: | http://www.ijhonline.org/article.asp?issn=2072-8069;year=2020;volume=9;issue=2;spage=155;epage=159;aulast=Al-Rekabi |
Similar Items
-
Prognostic values of β2 microglobulin, interleukin-4, and interleukin-6 in patients with different stages of chronic lymphocytic leukemia
by: Intisar Shakir Ali, et al.
Published: (2020-01-01) -
The Prognostic Value of CD49d Expression in Turkish Patients with Chronic Lymphocytic Leukemia
by: Ant Uzay, et al.
Published: (2012-12-01) -
Flow Cytometric Expression of CD49d in Newly Diagnosed Chronic Lymphocytic Leukemia and Its Correlation with Established Prognostic Markers
by: Arathi Kunnumbrath, et al.
Published: (2022-12-01) -
Beta2-Microglobulin as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram
by: Lin Q, et al.
Published: (2023-10-01) -
THE ROLE OF CD49D IN CHRONIC LYMPHOCYTIC LEUKAEMIA: MICROENVIRONMENTAL INTERACTIONS AND CLINICAL RELEVANCE
by: Michele Dal Bo, et al.
Published: (2014-07-01)